You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Correction: MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy

https://doi.org/10.1136/jitc-2020-002029corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Wang J, Shang Z, Wang J, et al. MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy. J Immunother Cancer 2021;9:e002029. doi:10.1136/jitc-2020-002029

    In the original published article, the funding statement was incomplete. The “(No. 8170211 to MX)” lost a number.

    The correct funding statement is: This work was supported by the National Natural Science Foundation of China (No. 81 770 211 to MX) and the National Natural Science Foundation of China (No.81830008 to JZ).